What is the clinical evidence from this study?

Study design: Other. Population: Catecholaminergic Polymorphic Ventricular Tachycardia. Intervention: K201 vs. Wild-type (WT) mice and myocytes. Primary outcome: Pacing-induced delayed afterdepolarizations (DADs) (p=0.001).

What does this research mean for the field?

In catecholaminergic polymorphic ventricular tachycardia (CPVT), the RyR2(R4496C+/-) mutation induces delayed afterdepolarizations and triggered activity that are not prevented by K201, and the mutation does not alter the RyR2-FKBP12.6 interaction. Novelty: ClaimNovelty.CONTRADICTORY. Consensus alignment: ConsensusAlignment.NEUTRAL.

What question did this study set out to answer?

To determine the electrophysiological mechanisms driving CPVT arrhythmias, evaluate whether the RyR2 mutation alters FKBP12.6 binding, and assess the therapeutic efficacy of K201.

July 7, 2006Circulation Research

Arrhythmogenesis in Catecholaminergic Polymorphic Ventricular Tachycardia

View Full Paper

Ask AI

Bookmark

Key result

Pacing induced delayed afterdepolarizations in 63% of RyR2(R4496C+/-) myocytes versus 0% in wild-type (P=0.001), and K201 failed to prevent these arrhythmias in vivo or in vitro.

Population

Ventricular myocytes isolated from wild-type and knock-in mice harboring the R4496C mutation (RyR2)

Comparison

In vitro application of isoproterenol… vs Wild-type (WT) mice/myocytes

Design

Preclinical

Authors

NLNian LiuShenyang Pharmaceutical University BCBarbara ColombiIstituti Clinici Scientifici Maugeri MMMirella MemmiIstituti Clinici Scientifici Maugeri

Discussion

Member takes

Implication

Supports triggered activity via DADs as CPVT mechanism in RyR2-R4496C model; challenges FKBP12.6 hypothesis and K201 efficacy.

Key Points

To determine the electrophysiological mechanisms driving CPVT arrhythmias, evaluate whether the RyR2 mutation alters FKBP12.6 binding, and assess the therapeutic efficacy of K201.
Isolated ventricular myocytes from wild-type (WT) and knock-in mice harboring the RyR2(R4496C+/-) mutation were analyzed under electrical pacing and 30 nmol/L isoproterenol superfusion.
Evaluated the antiarrhythmic effects of ryanodine (10 µmol/L) and K201 (1 to 10 µmol/L) in vitro, alongside in vivo K201 administration during arrhythmia induction.
Measured FKBP12.6/RyR2 binding ratios in heavy sarcoplasmic reticulum membranes before and after epinephrine and caffeine exposure.
Pacing protocols induced delayed afterdepolarizations (DADs) in 63% (21/33) of RyR2(R4496C+/-) myocytes versus 0% (0/20) in WT myocytes (P=0.001).
Isoproterenol elicited DADs in 87% and triggered activity in 60% of RyR2(R4496C+/-) myocytes compared to 45% DADs and 0% triggered activity in WT myocytes (P=0.001).
Arrhythmic activity was abolished by ryanodine but not by K201 in vitro or in vivo, and the RyR2-FKBP12.6 interaction remained normal across both groups before and after treatment.

Structured PICO

Population

Ventricular myocytes isolated from wild-type (WT) and knock-in mice harboring the R4496C mutation (RyR2(R4496C+/-))

Intervention

In vitro application of isoproterenol, ryanodine, and K201; in vivo administration of K201

Comparator

Wild-type (WT) mice/myocytes

Outcome

Delayed afterdepolarizations (DADs), triggered activity, and induction of polymorphic ventricular tachycardia (VT)surrogate

Main Result

Absolute Event Rate: 63% vs 0%

p-value: p=0.001

Triggered activity is the likely arrhythmogenic mechanism of CPVT, and K201 does not prevent arrhythmias, suggesting the R4496C mutation does not interfere with the RyR2/FKBP12.6 complex.

Cite This Study

Liu et al. (2006) studied Catecholaminergic Polymorphic Ventricular Tachycardia. K201 vs. Wild-type (WT) mice and myocytes was evaluated on Pacing-induced delayed afterdepolarizations (DADs) (p=0.001). Pacing induced delayed afterdepolarizations in 63% of RyR2(R4496C+/-) myocytes versus 0% in wild-type (P=0.001), and K201 failed to prevent these arrhythmias in vivo or in vitro.

synapsesocial.com/papers/6a158b1dd64fa333899fcac2 https://doi.org/10.1161/01.res.0000235869.50747.e1

Topics

Ventricular arrhythmias

View Full Paper

Ask AI

Bookmark

Arrhythmogenesis in Catecholaminergic Polymorphic Ventricular Tachycardia

Discussion

Member takes

Implication

Key Points

Structured PICO

Main Result

Cite This Study

Topics

Arrhythmogenesis in Catecholaminergic Polymorphic Ventricular Tachycardia

Discussion

Member takes

Implication

Key Points

Structured PICO

Main Result

Cite This Study

Also Consider

Topics

Also Consider